COVID-19 Infection clinical trials
Showing 51–100 of 106 active trials. Describe your situation to see which ones you may be eligible for.
- KIDney Injury in Times of COVID-19 (KIDCOV)
- Natural History of Post-Coronavirus Disease 19 Convalescence at the National Institutes of Health
- Send-In Sample Collection for Comprehensive Analyses of Innate and Adaptive Immune Responses During Acute COVID-19 and Convalescence
- Understanding Immunity to the Flu Vaccine in COVID-19 Patients
- COVID-19 Survivorship Registry
- Assessment of the Psychosocial Impact of the COVID-19 Pandemic on the MD Anderson Cancer Center Workforce
- Determinants of SARS (Severe Acute Respiratory Syndrome)-COV2 (COVID-19) Persistence After Convalescence
- ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers
- Long-term Impact of Infection With Novel Coronavirus (COVID-19)
- A Study to Explore the Role of Gut Flora in COVID-19 Infection
- Impact of the Coronavirus (COVID-19) on Patients With Cancer
- A Biospecimen Collection Study of Leukapheresis-Derived Circulating Tumor Cells, Immune Cells, and Progenitor Cells.
- Prospective Clinical Evaluation of the BioFire Emerging Coronavirus Panel for the Detection of COVID-19 and Other Coronaviruses
- Preparedness Through Respiratory Virus Epidemiology and Community Engagement
- Predictors of Post-COVID-19 Clinical and Cognitive Consequences
- Influenza & COVID-19 Obstetric and Perinatal Epidemiology Study in India
- Clinical Outcomes and Pharmacotherapy Effectiveness in the VA Health Care System (COPE-VA)
- The Impact of COVID-19 on Pulmonary Procedures
- Collection of SARS CoV-2 (COVID-19) Virus Secretions and Serum for Countermeasure Development
- COVID-19 Health Adjustments in Nutrition, General Wellness, and Exercise
- Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
- Viral Infections in Healthy and Immunocompromised Hosts
- A Pilot Clinical Evaluation of Astepro® Nasal Spray for Management of Early SARS-CoV-2 Infection
- Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study
- Imaging Immune Activation in COVID-19
- Covid-19 Long Haul Preventative and Health Promotion Care Clinical Trial Acceleration Program.
- Addressing Vaccine Acceptance in Carceral Settings Through Community Engagement
- Exercise in Child Health
- Improving the Collaborative Health of Minority COVID-19 Survivor and Carepartner Dyads
- The Effects of Endotracheal Suctioning on Pain and Serum Markers
- mRNA Covid-19 Vaccine Immune Response Comparisons Using Different Delivery Routes
- Personalized Ventilator Settings for Patients on ECMO
- Clinical Validation of the Aptitude Medical Systems Metrix Respiratory Panel Test in At-Home/Non-Laboratory Settings
- C11 ER176 PET in Evaluating Neuroinflammation in Patients With Post-COVID Syndrome
- ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection
- SPI-1005 Treatment in Moderate COVID-19 Patients
- Assessing the System for High-Intensity Evaluation During Radiotherapy During Changes in Response to COVID-19
- A Spatial Analysis of Hotspots and Targeted Injection Settings Pilot Intervention for HIV Prevention Among People Who Inject Drugs
- You and Me Healthy
- COVID-19 Experiences in the SELF Cohort
- Drum Circle Synchrony Study 2c.a.
- Trans Thoracic Manipulation of Ventilation/Perfusion: the V/Q System
- Patient-Centered Practical Vaccine Talk For Busy Clinicians
- A Nasal Treatment for COVID-19
- Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia
- Study of VYD2311 for the Prevention of COVID-19
- Safety and Tolerability of a Newcastle Disease Virus-Based Mucosal COVID-19 Vaccine in Previously Vaccinated Adults
- Comparative Immunogenicity of Respiratory Virus Vaccines (CIRV2) Study
- A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes
- Long COVID Immune Profiling
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.